ETF

First Trust NYSE Arca Biotech ETFAUSDAcc

ISIN
IE00BL0L0H60

How good is this fund, really?

See the rating in the app

About First Trust NYSE Arca Biotech ETFAUSDAcc

Biotechnology stocks in the NYSE Arca Biotechnology Index form the portfolio of First Trust NYSE Arca Biotech ETFAUSDAcc. The goal is to deliver results broadly in line with that index's price and yield, which the fund pursues by replication, owning constituents in similar proportions before fees. Depositary receipts can replace hard-to-buy constituents. Passive management keeps expected tracking error at 0-2% in normal conditions. First Trust Advisors L.P. is investment manager, and First Trust Global Portfolios Management Limited manages First Trust Global Funds ICAV, the umbrella. Income is reinvested in this Class A US dollar share, launched in May 2020. Its key investor information document puts the fund in risk category 6 of 7 and notes it may not suit those who plan to withdraw money in the short term. The yearly ongoing charge is 0.60%.

Watch this fund for free Add First Trust NYSE Arca Biotech ETFAUSDAcc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy First Trust NYSE Arca Biotech ETFAUSDAcc — platforms and fees

Sold on 2 platforms we follow.

First Trust NYSE Arca Biotech ETFAUSDAcc — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds